Our aims are:

  • To promote the knowledge and understanding of clinical drug analysis and interpretation of results.

 

  • To enhance communication between scientists and physicians of all disciplines involved in therapeutic drug monitoring and clinical toxicology.

 

  • To encourage the effective application of therapeutic drug monitoring and clinical toxicology; with the aim of optimizing clinical drug use and maximizing the clinical and economic benefits.

 

Application form (PDF) (Word)

Journal

IATDMCT is assuming ownership of Therapeutic Drug Monitoring journal

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

Instructions for authors

Latest News

  • 11th International Congress of TDM & Clinical Toxicology ,
    • October 3-8, 2009 Montreal Canada

  • Call for applications for Congress 2013 NEW
    Application form   - Congress profile
  • New report from the Biomarker working group (BWG) within the Immunosuppressive Committee
  • Pharmacodynamic Markers as a Tool to Optimize Immunosuppression in Transplantation Medicine", under the auspices of IATDMCT, Friday, July 10, 2009 between 10:30 am and 05:00 pm, Mövenpick Hotel Stuttgart Airport.

  • Election Results Announced

    •
  • International Travel grant
    •
  • Committee pages updated

  • Deuterated internal standards
  • New Membership Terms of Reference (see bottom of Membership page)
    •




      Members pages are only accessible to members who have paid their dues.
      They contain the directory of members, monographs on digoxin, theophyllin, cyclosporin and tacrolimus, the newsletters and two articles on Busulfan monitoring by L. Langman and Pharmacogenomics for Clinical and Forensic Toxicology. An Adjunct for Interpretation of Drug Toxicity by Shi et al.

      P.O. Box 1570, 4 Cataraqui Street,
      Suite 310, Kingston, Ontario K7L 5C8 Canada,
      Tel: 613-531-8166 • Fax: 613-531-0626,
      E-mail:       office@iatdmct.org

       

    Powered By Dragonfly IT Ltd.